Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The company focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.
최신 재무제표(Form-10K)에 따르면, Nu-Med Plus Inc의 총 자산은 $0이며, 순손실입니다.
NUMD의 주요 재무 비율은 무엇인가요?
Nu-Med Plus Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Nu-Med Plus Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Nu-Med Plus Inc 주요 수익원은 Leaf Lettuce, Arugula, Spinach, and Basil이며, 최신 수익 발표에서 수익은 38,138,000입니다. 지역별로는 United States이 Nu-Med Plus Inc의 주요 시장이며, 수익은 38,138,000입니다.